Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Cencora, Inc.

COR · NYSE · CIK 0001140859 · Healthcare · Medical Distribution

INSIDER SIGNAL

No active buy signal

3 qualifying P purchase groups
in the current 180-day scoring window

16 Form 4 transaction lines observed in the same window
4 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2026-06-22 · Tyler Lauren M · $148.6K

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying3 qualifying line group(s)
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Tyler Lauren MDirector
○●○
Krikorian LazarusSVP & Chief Accounting Officer
▼▼
Campbell Elizabeth SExecutive Vice President
○▼
NALLY DENNIS MDirector
○○
Cooper EllenDirector
○○
DURCAN DERMOT MARKDirector
●●
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION94%Largest buyer: DURCAN DERMOT MARK · $2.2M
CLUSTER BUYING · 15D2 insidersPeak activity: 2026-06-18–2026-06-22

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-06-22 · Tyler Lauren M.

Recent Form 4 activity

3Purchases
13Sales
93Other Form 4 lines
66SEC filings · 365 days
BUYING3 qualifying P line(s) · 180 days
SELLING4 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
3,919,355
Previous report
4,311,607
Avg daily volume
1,369,940
Days to cover
2.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-22Tyler Lauren MPurchase (P)Common Stock550USD 270.23USD 148,626SEC filing ↗
2026-06-18DURCAN DERMOT MARKPurchase (P)Common Stock4,000USD 274.19USD 1,096,760SEC filing ↗
2026-05-28DURCAN DERMOT MARKPurchase (P)Common Stock4,000USD 266.26USD 1,065,040SEC filing ↗
2024-05-24DURCAN DERMOT MARKPurchase (P)Common Stock500USD 218.58USD 109,290SEC filing ↗
2020-03-23DURCAN DERMOT MARKPurchase (P)Common Stock1,350USD 74.33USD 100,346SEC filing ↗
2020-03-13DURCAN DERMOT MARKPurchase (P)Common Stock1,225USD 82.62USD 101,210SEC filing ↗

Form 4 evidence

109 transaction lines in the latest 365-day window; 922 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01SANCHEZ ROBERT EAward / grant (A)Common Stock275USD —USD —SEC filing ↗
2026-10-01Krikorian LazarusSale (S)Common Stock986USD 303.18USD 298,935SEC filing ↗
2026-09-16GREENBERG LON RSale (S)Common Stock1,280USD 321.30USD 411,264SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01SANCHEZ ROBERT EAward / grant (A)Common Stock275USD —USD —SEC filing ↗
2026-10-01Krikorian LazarusSale (S)Common Stock986USD 303.18USD 298,935SEC filing ↗
2026-09-16GREENBERG LON RSale (S)Common Stock1,280USD 321.30USD 411,264SEC filing ↗
2026-09-01Krikorian LazarusSale (S)Common Stock985USD 325.97USD 321,080SEC filing ↗
2026-08-24Campbell Elizabeth SSale (S)Common Stock11,300USD 324.12USD 3,662,708SEC filing ↗
2026-07-31Tyler Lauren MAward / grant (A)Common Stock97USD 311.34USD 30,200SEC filing ↗
2026-07-31NALLY DENNIS MAward / grant (A)Common Stock113USD 311.34USD 35,181SEC filing ↗
2026-07-31Cooper EllenAward / grant (A)Common Stock97USD 311.34USD 30,200SEC filing ↗
2026-06-30Campbell Elizabeth SAward / grant (A)Common Stock50USD 240.53USD 12,000SEC filing ↗
2026-06-30Battaglia SilvanaAward / grant (A)Common Stock58USD 240.53USD 13,999SEC filing ↗
2026-06-22Tyler Lauren MPurchase (P)Common Stock550USD 270.23USD 148,626SEC filing ↗
2026-06-18DURCAN DERMOT MARKPurchase (P)Common Stock4,000USD 274.19USD 1,096,760SEC filing ↗
2026-05-28DURCAN DERMOT MARKPurchase (P)Common Stock4,000USD 266.26USD 1,065,040SEC filing ↗
2026-05-01Tyler Lauren MAward / grant (A)Common Stock99USD 304.00USD 30,096SEC filing ↗
2026-05-01NALLY DENNIS MAward / grant (A)Common Stock116USD 304.00USD 35,264SEC filing ↗
2026-05-01Cooper EllenAward / grant (A)Common Stock99USD 304.00USD 30,096SEC filing ↗
2026-03-11Cleary James FOption exercise / conversion (M)Common Stock12,623USD 0.00USD 0SEC filing ↗
2026-03-11Cleary James FTax withholding (F)Common Stock5,409USD 350.30USD 1,894,773SEC filing ↗
2026-03-11Campbell Elizabeth SOption exercise / conversion (M)Common Stock12,623USD 0.00USD 0SEC filing ↗
2026-03-11Campbell Elizabeth STax withholding (F)Common Stock5,842USD 350.30USD 2,046,453SEC filing ↗
2026-03-11Battaglia SilvanaOption exercise / conversion (M)Common Stock8,415USD 0.00USD 0SEC filing ↗
2026-03-11Battaglia SilvanaTax withholding (F)Common Stock3,673USD 350.30USD 1,286,652SEC filing ↗
2026-03-05Tyler Lauren MAward / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗
2026-03-05Ryerkerk LoriAward / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗
2026-03-05NALLY DENNIS MAward / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗
2026-03-05Miller RedondaAward / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗
2026-03-05Kim Lorence H.Award / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗
2026-03-05GREENBERG LON RAward / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗
2026-03-05DURCAN DERMOT MARKAward / grant (A)Common Stock905USD 359.28USD 325,148SEC filing ↗
2026-03-05Cooper EllenAward / grant (A)Common Stock557USD 359.28USD 200,119SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCOR
CIK0001140859
SectorHealthcare
IndustryMedical Distribution Yahoo Finance
SEC SIC5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNYSE

Data coverage

Local Form 4 history922 transaction lines from 2020-01-06 to 2026-10-01
6 P purchase lines · 218 S sale lines · 698 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.